Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1.
暂无分享,去创建一个
A. Falabella | L. Zhou | H. Murata | V. Falanga | V Falanga | H Murata | A Falabella | A. Hasan | S. Ochoa | E. Badiavas | A Hasan | S Ochoa | L Zhou | E Badiavas | L. Zhou
[1] J. Kruskal,et al. Fibrin- and fibrinogen-related antigens in patients with venous disease and venous ulceration. , 1991, Archives of dermatology.
[2] D. M. Cooper,et al. Safety and effect of transforming growth factor‐β2 for treatment of venous stasis ulcers , 1995, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[3] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[4] T. Fahey,et al. Differential TNF secretion by wound fibroblasts compared to normal fibroblasts in response to LPS. , 1995, The Journal of surgical research.
[5] B. Gilchrest,et al. Experimental approaches to chronic wounds , 1995, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[6] F A Auger,et al. Human wound healing fibroblasts have greater contractile properties than dermal fibroblasts. , 1994, The Journal of surgical research.
[7] M. Sporn,et al. Hypoxia upregulates the synthesis of tgf-β1 by human dermal fibroblasts , 1991 .
[8] J. Dormandy,et al. Causes of venous ulceration: a new hypothesis , 1988 .
[9] H. Takagi,et al. Enhanced collagen synthesis and transcription by peak E, a contaminant of L-tryptophan preparations associated with the eosinophilia myalgia syndrome epidemic. , 1995, The Journal of clinical investigation.
[10] R. Kirsner,et al. Low oxygen tension increases mRNA levels of alpha 1 (I) procollagen in human dermal fibroblasts , 1993, Journal of cellular physiology.
[11] M. Sporn,et al. Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. , 1987, Science.
[12] W. Harvey,et al. A quantitative assay for collagen synthesis in microwell fibroblast cultures. , 1979, Analytical biochemistry.
[13] J. Myers,et al. Cloning and characterization of five overlapping cDNAs specific for the human pro alpha 1(I) collagen chain. , 1982, Nucleic acids research.
[14] A. Roberts,et al. Transforming growth factor‐β: activity and efficacy in animal models of wound healing , 1995, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[15] J. Peltonen,et al. Platelet-derived growth factor isoforms PDGF-AA, -AB and -BB exert specific effects on collagen gene expression and mitotic activity of cultured human wound fibroblasts. , 1995, Biochemical and biophysical research communications.
[16] Anita B. Roberts,et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells , 1985, Nature.
[17] W. Eaglstein,et al. The "trap" hypothesis of venous ulceration , 1993, The Lancet.
[18] K. Burnand,et al. THE CAUSE OF VENOUS ULCERATION , 1982, The Lancet.
[19] M. Sporn,et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[20] F. Grinnell,et al. Degradation of Fibronectin and Vitronectin and Vitronectin in Chronic Wound Fluid: Analysis by Cell Blotting, Immunoblotting, and Cell Adhesion Assays , 1992 .
[21] R. Weinberg,et al. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase , 1992, Cell.
[22] V. Falanga,et al. Extravasation of macromolecules and possible trapping of transforming growth factor‐β in venous ulceration , 1995, The British journal of dermatology.
[23] C. McCollum,et al. Venous ulcer fibroblasts compared with normal fibroblasts show differences in collagen but not fibronectin production under both normal and hypoxic conditions. , 1996, The Journal of investigative dermatology.